Spots Global Cancer Trial Database for Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™
Official Title: Prospective National Post-marketing Surveillance for the Investigation of the Efficacy and Safety of SpaceOAR™ to Maintain Space Between the Rectum and Prostate During Radiation Therapy
Study ID: NCT01999660
Interventions
Study Description
Brief Summary: A treatment with SpaceOAR™ hydrogel does reduce late toxicity Grad 2 and Grad 3 of radiation therapy in prostate cancer patients
Detailed Description: The degradable SpaceOAR™ hydrogel establishes for the time of radiotherapy a distance between the prostate and the rectum
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Clinic for Radiooncology and Radiotherapy, Evangelical Clinics Gelsenkirchen, Gelsenkirchen, NRW, Germany
Contact Details
Name: Razvan Galalae, PD Dr. med.
Affiliation: Clinic for Radiooncology and Radiotherapy, Evangelical Clinics Gelsenkirchen, Germany
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
